Skip to main content (Press Enter).
Login
Skip auxiliary navigation (Press Enter).
About Telegraft
Cytotherapy
Career Center
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
ISCT Home
Telegraft Hub Home
Cytotherapy
Career Center
Contact Us
ISCT Communities
News Hub
Members in the News : Ori Biotech
Recommend
Members in the News:
Ori Biotech and CTMC partner to accelerate novel cell therapy delivery
London, UK, and Houston, TX, US, September 13, 2022 –
Ori Biotech
(Ori), a leader in cell and gene therapy (CGT) manufacturing technologies, and the
Cell Therapy Manufacturing Center
(CTMC), a joint venture between
National Resilience Inc
and
MD Anderson Cancer Center
, today announce a collaborative partnership to develop industrial manufacturing processes for cell therapies.
Read the Full Release
Here
This press release was written and distributed by CCRM
For all enquiries, please contact CCRM directly
#IndustryMemberNews
#29.8
0 comments
12 views
Permalink
View other ISCT news:
Most Recent Posts
Perspectives for Certification of ATMP Therapy Centers: Role of JACIE
20 days ago
Blog Entry
FACT Accreditation is Meeting Growing Demand and Promoting Patient Access to Quality Cellular Therap ...
20 days ago
Blog Entry
Elevate your cell manufacturing with Miltenyi Biotec’s CliniMACS® Formulation Unit
20 days ago
Blog Entry
Powered by Higher Logic